Baystate Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Baystate Wealth Management's MDT Position: Q4 2023 in Review
Baystate Wealth Management reduced its Medtronic (MDT) stake by 5.1% in Q4 2023, selling an estimated $1.45K and leaving 350 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #488.
Baystate Wealth Management first reported a position in MDT in Q4 2016 and has held it in 29 quarters since. The position peaked at $157K in Q1 2017. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- Baystate Wealth Management held 350 shares of Medtronic worth $28.9K as of Q4 2023.
- Baystate Wealth Management sold 19 Medtronic shares in Q4 2023, an estimated $1.45K.
- Medtronic made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #488 holding.
- Baystate Wealth Management first reported a position in Medtronic in Q4 2016 and has held it in 29 quarters since.
- Baystate Wealth Management's Medtronic position peaked at $157K in Q1 2017.
- 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.